Today's story
GE HealthCare Plans $945 Million SOFIE Acquisition
GE HealthCare agreed to acquire SOFIE Biosciences for $945 million in cash, expanding its U.S. PET radiopharmaceutical manufacturing and distribution network and strengthening its position in the growing precision-imaging market. The deal, expected to close in the first half of 2027 pending regulatory approval, also gives GE HealthCare U.S. rights to the Phase III imaging agent FAPI-74.
Business · 12 sources · 4hRead itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Sofie
The Surgeon’s Operating Force-feedback Interface Eindhoven (SOFIE) surgical robot is a surgical robot developed at the Eindhoven University of Technology. It was developed as part of a Ph.D. thesis by Dr. Ir. Linda van den Bedem and is the first surgical robot to incorporate force feedback.
Everything about Sofie →